Lei Lei

Dr. Lei Lei


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
HQHaolong Qi
Haolong Qi
BWBin Wang
Bin Wang
LLLei Lei
Lei Lei
Background: The associations of serum calcium and phosphorus with nonalcoholic fatty liver disease (NAFLD) remain unclear. In addition, there may be an effect of albumin correction on the association between serum calcium and NAFLD. We aimed to explore these relationships in the National Health and Nutrition Examination Survey (NHANES).Methods: Eligible adult individuals from NHANES 1999-2018 were recruited for the study. We explored the associations of serum calcium, albumin-adjusted serum calcium, and serum phosphorus with NAFLD in multivariable-adjusted regression models. In addition, restricted cubic spline (RCS), stratified analysis, and multiple sensitivity analyses were used for further elaboration.Results: The study sample consisted of 20,900 participants, with an observed NAFLD prevalence of 44.65%. Fully adjusted models indicated that serum calcium was inversely associated with NAFLD (odds ratio [OR] and 95% confidence interval [CI] = 0.70 (0.62, 0.78), p<0.0001), whereas albumin-adjusted serum calcium was positively associated with NAFLD (OR and 95% CI=1.59 (1.41, 1.79), p<0.0001). RCS modeling indicated that serum calcium without and with albumin adjustment was linearly(p nonlinear = 0.083) and nonlinearly (p nonlinear < 0.0001) associated with NAFLD, respectively, whereas serum phosphorus showed a U-shaped relationship with NAFLD(p nonlinear < 0.0001). Gender is a significant influence in all associations, and other variables may also have an effect. Sensitivity analyses indicated that these associations were independent of additional significant confounders.Conclusion: Serum calcium and phosphorus were significantly associated with the development of NAFLD. These findings suggest the potential clinical significance of serum calcium/phosphorus and albumin levels in individuals at high risk for NAFLD. Our study supports the potential role of serum calcium/phosphorus homeostasis in the pathophysiology of NAFLD and could serve as NAFLD-related biomarkers.

13 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
YZYanbing Zhang
Yanbing Zhang
XZXinge Zhang
Xinge Zhang
CHChuiguo Huang
Chuiguo Huang
LLLei Lei
Lei Lei
Background/Objectives: Recently, the term metabolic dysfunction-associated steatotic liver disease (MASLD) has replaced non-alcoholic fatty liver disease (NAFLD). Through analysis of the trends and disparities regarding cardiovascular disease (CVD) among individuals with MASLD, identifying the leading cause of death in this population is crucial. Methods: We conducted a cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES) III (1988–1994) and NHANES 2017–2020 data. MASLD was identified by using clinical profiles and liver ultrasonography to exclude other liver diseases. We estimated the prevalence of CVD among individuals with MASLD and calculated the prevalence ratios for those with and without MASLD. Results: In 2017–2020, MASLD affected 31.2% or 61.9 million US adults, and 17.0% (95% confidence interval: 13.7–20.3%) of these individuals had CVD. The absolute CVD prevalence in individuals with MASLD doubled from that in the NHANES III cohort, which was 8.7% (6.4%, 10.9%). These increases were especially notable among older adults, non-Hispanic whites, and those with higher education and income. Individuals with MASLD had a higher prevalence of total CVD than those without MASLD, even after adjusting for socioeconomic and metabolic factors. These differences were more pronounced in younger age groups. Conclusions: This study revealed a doubled 30-year trend in CVD prevalence among adults with MASLD in the US. Sociodemographic disparities emphasize the need for tailored screening, prevention, and policy measures to address gaps and promote cardiovascular health in this population.

21 January 2024 in Arab Journal of Gastroenterology
Verified
Journal Article
Closed access
JSJiajia Sun
Jiajia Sun
WLWei Liu
Wei Liu
HFHao Fu
Hao Fu
YLYibei Li
Yibei Li
JHJiaqi Huang
Jiaqi Huang
LLLei Lei
Lei Lei

31 December 2025 in Research Square
Verified
Preprint
Open access
PDF file
LLLei Lei
Lei Lei
QHQi Han
Qi Han
BPBei Pei
Bei Pei
JZJie Zhang
Jie Zhang
HQHaolong Qi
Haolong Qi
Background: Gastroparesis is a debilitating disorder characterized by delayed gastric emptying without mechanical obstruction, carrying significant mortality risks. Accurate prediction of mortality remains challenging due to the condition's heterogeneous nature. This study aimed to develop and validate machine learning models for predicting both short-term and long-term mortality in patients with gastroparesis. Methods: This retrospective cohort study utilized data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Adult patients diagnosed with gastroparesis between 2003 and 2019 were included. Comprehensive clinical data encompassing demographics, laboratory parameters, comorbidities, and severity scores were extracted. Seven machine learning algorithms were employed to predict 30-day and 365-day mortality: logistic regression, support vector machine, random forest, k-nearest neighbors, decision tree, artificial neural network, and gradient boosting machine. Model performance was evaluated using area under the receiver operating characteristic curve (AUC-ROC), accuracy, precision, recall, and F1-score. Results: Among 6,125 eligible patients with gastroparesis, the random forest model demonstrated superior performance for both 30-day (AUC: 0.39) and 365-day mortality prediction (AUC: 0.905). Key predictors included age, red cell distribution width (RDW), Charlson comorbidity index, white blood cell count, and renal function markers. Significant mortality associations were identified for ICU admission, sepsis, acute kidney injury, and liver diseases. Conclusions: Machine learning algorithms, particularly random forest, effectively predict mortality risk in gastroparesis patients using routinely available clinical data. These models provide valuable tools for risk stratification and informed clinical decision-making, potentially improving patient outcomes through early identification of high-risk individuals.